Ohio State Eye and Ear Institute

Columbus, Ohio 43212

1 studies enrolling now · 4 studies all time

What they study most

Advanced Malignancies Except Leukemia, Diabetic Macular Edema, Non-Small Cell Lung Cancer ALK-positive, Non-Small Cell Lung Cancer ROS Marker Positive, Non-Small Cell Lung Cancer c-Met Dependent, Non-small Cell Lung Cancer, Systemic Anaplastic Large-Cell Lymphoma, Uveal Melanoma

Studies at this site

• Neoadjuvant Darovasertib in Primary Uveal Melanoma — Recruiting now
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema — Completed
• An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer — Completed
• A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer — Completed